The feasibility of reduced-intensity allogeneic hematopoietic stem cell transplantation from a related donor with HLA one-antigen with or without one-allele mismatch

Kunihisa Nakai, Shin Mineishi, Masahiro Kami, Yoshinobu Konda, Ryuji Tanosaki, Yoichi Takaue

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

It is still unclear whether reduced-intensity stem cell transplantation (RIST) from an HLA-mismatched related donor is feasible for hematologic malignancies. In the current study on the use of antithymocyte globulin (ATG) in 13 patients, we focused on this issue by evaluating regimenrelated toxicities, engraftment, graft-versus-host disease (GVHD), infection, and overall survival. Our results suggest that this procedure may be acceptable for patients without a matched related donor.

Original languageEnglish
Pages (from-to)115-117
Number of pages3
JournalHaematologica
Volume88
Issue number1
Publication statusPublished - 2003 Feb 1
Externally publishedYes

Fingerprint

Hematopoietic Stem Cell Transplantation
HLA Antigens
Alleles
Tissue Donors
Antilymphocyte Serum
Stem Cell Transplantation
Graft vs Host Disease
Hematologic Neoplasms
Survival
Infection

Keywords

  • Engraftment
  • GVHD
  • Mismatched reduced-intensity stem cell transplantation

ASJC Scopus subject areas

  • Hematology

Cite this

The feasibility of reduced-intensity allogeneic hematopoietic stem cell transplantation from a related donor with HLA one-antigen with or without one-allele mismatch. / Nakai, Kunihisa; Mineishi, Shin; Kami, Masahiro; Konda, Yoshinobu; Tanosaki, Ryuji; Takaue, Yoichi.

In: Haematologica, Vol. 88, No. 1, 01.02.2003, p. 115-117.

Research output: Contribution to journalArticle

Nakai, Kunihisa ; Mineishi, Shin ; Kami, Masahiro ; Konda, Yoshinobu ; Tanosaki, Ryuji ; Takaue, Yoichi. / The feasibility of reduced-intensity allogeneic hematopoietic stem cell transplantation from a related donor with HLA one-antigen with or without one-allele mismatch. In: Haematologica. 2003 ; Vol. 88, No. 1. pp. 115-117.
@article{683a5a67c97e4698a5457a494fdecbcd,
title = "The feasibility of reduced-intensity allogeneic hematopoietic stem cell transplantation from a related donor with HLA one-antigen with or without one-allele mismatch",
abstract = "It is still unclear whether reduced-intensity stem cell transplantation (RIST) from an HLA-mismatched related donor is feasible for hematologic malignancies. In the current study on the use of antithymocyte globulin (ATG) in 13 patients, we focused on this issue by evaluating regimenrelated toxicities, engraftment, graft-versus-host disease (GVHD), infection, and overall survival. Our results suggest that this procedure may be acceptable for patients without a matched related donor.",
keywords = "Engraftment, GVHD, Mismatched reduced-intensity stem cell transplantation",
author = "Kunihisa Nakai and Shin Mineishi and Masahiro Kami and Yoshinobu Konda and Ryuji Tanosaki and Yoichi Takaue",
year = "2003",
month = "2",
day = "1",
language = "English",
volume = "88",
pages = "115--117",
journal = "Haematologica",
issn = "0390-6078",
publisher = "Ferrata Storti Foundation",
number = "1",

}

TY - JOUR

T1 - The feasibility of reduced-intensity allogeneic hematopoietic stem cell transplantation from a related donor with HLA one-antigen with or without one-allele mismatch

AU - Nakai, Kunihisa

AU - Mineishi, Shin

AU - Kami, Masahiro

AU - Konda, Yoshinobu

AU - Tanosaki, Ryuji

AU - Takaue, Yoichi

PY - 2003/2/1

Y1 - 2003/2/1

N2 - It is still unclear whether reduced-intensity stem cell transplantation (RIST) from an HLA-mismatched related donor is feasible for hematologic malignancies. In the current study on the use of antithymocyte globulin (ATG) in 13 patients, we focused on this issue by evaluating regimenrelated toxicities, engraftment, graft-versus-host disease (GVHD), infection, and overall survival. Our results suggest that this procedure may be acceptable for patients without a matched related donor.

AB - It is still unclear whether reduced-intensity stem cell transplantation (RIST) from an HLA-mismatched related donor is feasible for hematologic malignancies. In the current study on the use of antithymocyte globulin (ATG) in 13 patients, we focused on this issue by evaluating regimenrelated toxicities, engraftment, graft-versus-host disease (GVHD), infection, and overall survival. Our results suggest that this procedure may be acceptable for patients without a matched related donor.

KW - Engraftment

KW - GVHD

KW - Mismatched reduced-intensity stem cell transplantation

UR - http://www.scopus.com/inward/record.url?scp=0037311030&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037311030&partnerID=8YFLogxK

M3 - Article

C2 - 12551837

AN - SCOPUS:0037311030

VL - 88

SP - 115

EP - 117

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 1

ER -